The Certificate Is Genuine and Stale

ON THIS PAGE

1. Key findings
2. The three dates, and the order they should fall in
3. When the lot number is missing entirely
4. When the certificate is older than the domain
5. When the lab has newer results the page does not show
6. Why nothing sets an expiry
7. What a buyer can actually check
8. Limitations and open questions
9. Sources

A certificate can be completely genuine, issued by a real laboratory for a real batch that really measured what it says, and still tell a buyer almost nothing about the vial being sold today. The document does not go bad. The question of whether it still describes the product in front of a buyer is a separate one, and it turns on three dates most readers never check in order.

The three dates, and the order they should fall in

A certificate of analysis typically carries a received date, when the sample reached the lab, a tested date, when the analysis was actually run, and a reported or issued date, when the document was finalized. Not every certificate prints all three. Noble Chems' retatrutide 10mg certificate, read 2026-08-26, carries no received date anywhere on its face: it shows a tested date of 3/29/2026, a document date of 4/3/2026, five days later, and a digital signature stamped 2026.05.28, close to two months after the date printed on the document it signs. Five days from test to report is unremarkable. Two months from report to signature is harder to read, and nothing on the certificate explains it. Even so, the internal order is not the gap that does the most damage to a buyer. That one sits between the reported date on the document and the date a buyer is actually reading it, alongside a second, separate gap between the lot the certificate names and the lot number, if any, printed on the vial or the product page. A certificate with no lot number to check against is a certificate a buyer cannot actually tie to anything, however current its internal dates are.

When the lot number is missing entirely

Forward Peptides' retatrutide product page, read 2026-08-25, publishes a certificate dated six months before the read date, and the page carries no lot number anywhere for a buyer to check the certificate against. Two separate product listings for the same compound load the identical certificate file, so the two pages are not distinguishable by batch either. A buyer reading that certificate has confirmed a lab ran a test on some lot, on some date, six months ago. Nothing on the page ties that lot to whatever ships when an order is placed today.

When the certificate is older than the domain

The clearest case in this ledger belongs to Chimera Peptides. The domain that publishes its certificates, read 2026-08-25, was registered on 2026-04-05, roughly four and a half months before the read. Every certificate the site publishes predates that registration date. The documents are not fabricated, and the underlying lab work may be entirely real, but every one of them was issued before the address now presenting them existed. What that does not establish is when the business behind the storefront began operating. The same ledger record holds two facts that cut against the tidier reading: an unhyphenated sibling domain under the same brand name was registered 2025-10-08, though it sits on client hold today and does not resolve, and Finnrick, the testing-verification brand whose mark several of these certificates carry, keeps a public tracking page for this storefront showing dated tests running from 13 Oct 2025, months before the current domain was registered. So the claim here is the narrow one and nothing past it: the certificates are older than the domain publishing them. A reader who checks only whether the lab is real and the batch number resolves would still miss that, because both of those checks can pass while the certificate's relationship to the site displaying it stays unestablished.

When the lab has newer results the page does not show

Full Scale Peptides' published retatrutide certificate, read 2026-08-25, is dated six months before the read. The staleness here is checkable without leaving the site: eight of the fourteen certificates in the vendor's own library were received and reported three months more recently than the retatrutide document, proving the laboratory has done newer work for this client that the retatrutide page simply does not show. A stale certificate next to fresher ones from the same source is a different, more specific finding than a stale certificate alone: it shows the newer document existed and was not the one selected for the page a buyer actually reads. Peptra Labs, read 2026-08-26, shows the same unevenness inside one catalog rather than one product: the retatrutide batch on file was tested more than five months before the read, while five other compounds on the identical page show a batch tested about one month before it. The benchmark compound is not being kept current at the same pace as the rest of the catalog it sits beside.

Why nothing sets an expiry

Federal drug regulation answers this question for manufactured drug products directly. 21 CFR 211.137 states that a drug product, "to assure that a drug product meets applicable standards of identity, strength, quality, and purity at the time of use, it shall bear an expiration date determined by appropriate stability testing described in § 211.166." That rule exists because a drug product is expected to degrade, and the regulation forces a manufacturer to say, in writing, how long the product can be trusted to still be what the label claims. No analogous rule requires an expiration or staleness date on a certificate of analysis for a peptide sold under a research-use label. Whether a given seller's marketing carries its product into drug-product territory is a separate and contested question, one this publication has covered in its reporting on FDA warning letters to peptide storefronts, and this piece takes no position on it either way. The point here is narrower than that argument: 211.137 dates the product, not the document a storefront publishes about it. The result is a genuine gap: nothing compels a seller to say how old is too old, and nothing stops a certificate from being reused for months or years after the lot it describes has been exhausted, sold, or superseded by a newer test. That is not a loophole anyone closed and reopened. It is a requirement that was never written for certificates in the first place.

What a buyer can actually check

Age alone does not disqualify a certificate. A compound that has not changed formulation or supplier does not necessarily need a new test every month, and several of the more thoroughly documented vendors in this ledger keep certificates current without anyone requiring it of them. What a buyer can check, in every case, is the order of the three dates against the lot on the vial: does the certificate name a lot that matches what shipped, is the reported date recent enough to plausibly cover the batch being sold, and does a search of the vendor's own library turn up anything newer for the same product that the page in front of a buyer does not show. Each of those questions has a checkable answer. None of them requires trusting the seller's own account of how current its documentation is.

Limitations and open questions

This piece describes five dated cases read between 2026-08-25 and 2026-08-26; a supplier's documentation can change at any time after those dates, and this piece makes no claim about any of these vendors' current certificate library. Whether a given certificate's age actually matters depends on facts this piece cannot establish for any specific vial, including whether the underlying compound is stable enough that a six-month-old test still describes it accurately. Chimera Peptides' domain-registration date is a fact about the storefront, not a finding about the laboratory work behind its certificates, and this piece takes no position on whether that lab work is otherwise sound.

A certificate's signature and letterhead answer whether a lab is real. Only the dates answer whether the test still describes the thing being sold.

Sources

21 CFR 211.137, the 2025 edition published at govinfo.gov, read 2026-09-18, for the expiration-dating requirement quoted above. Supplier observations are this publication's own, from the dossier record in ledger/vendors.json: Forward Peptides, Chimera Peptides, and Full Scale Peptides, all read 2026-08-25; Peptra Labs and Noble Chems, both read 2026-08-26. Vendors are named here, never linked, per site policy.